This protocol is judged by an institutional evaluation board, an independent group that opinions any medical trials involving individuals. If a study requires a Agenda I drug, when the board approves the protocol as ethical, the scientists must apply for an investigational new drug (IND) selection from your FDA.And since the copyright is going thr